UCM DataDrug
UCM DataDrug
UCM DataDrug
drug
UCB: Overview
• A global pharmaceutical company headquartered in Belgium
• Over 1000 research and development staff, spending 27 per cent of revenue
on research
• This experience with Watson sparked De Prins to realize that data and
analytics would revolutionize health care
• De Prins wanted to prepare his IT oraganisation for the “new digital normal”
• Future of IT, aimed to employ advanced analytics to make the data available
for secondary uses
• Health care data from external data was exploding; data from health care
providers, public and private payers, suppliers, digital patients, and smart
devices
• UCB IT leadership realized the value of tapping into this external data
• Looked for ways to mix and match the internal and external data
Sprints: Agile & Opportunistic
Method
• UCB : Great deal of data was available internally across the value chain
• Future of IT, aimed to employ advanced analytics to make the data available
for secondary uses
• Health care data from external data was exploding; data from health care
providers, public and private payers, suppliers, digital patients, and smart
devices
• UCB IT leadership realized the value of tapping into this external data
• Looked for ways to mix and match the internal and external data
Problems with Sprints
Businesses were reluctant to implement changes in spite of value
demonstrated
Process-
1. First sprints are to be used to
demonstrate potential value of a project Embed
2. A-B test to be used to prove that new
decision is better than old one
3. Lastly, insights to be embedded in the
work process